This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Drug Therapy, Other  • World Health  • Infectious Diseases  • Bacterial Infections  • Sexually Transmitted Diseases  • Pediatric Ophthalmology  • Ophthalmological Disorders, Other  • Pediatrics  • Pediatrics, Other  • Drug Therapy  • Public Health  • Alert me on articles by topic

Alfred Sommer, MD, MHS

Arch Ophthalmol. 2008;126(7):1000-1001.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

JAMA

Comparison of Annual and Biannual Mass Antibiotic Administration for Elimination of Infectious Trachoma

Muluken Melese, MD, MPH; Wondu Alemayehu, MD, MPH; Takele Lakew, MD, MPH; Elizabeth Yi, MPH; Jenafir House, MPH, MSW; Jaya D. Chidambaram, MBBS; Zhaoxia Zhou, BA; Vicky Cevallos, MT; Kathryn Ray, MA; Kevin Cyrus Hong, BA; Travis C. Porco, PhD, MPH; Isabella Phan, MD; Ali Zaidi, MD; Bruce D. Gaynor, MD; John P. Whitcher, MD, MPH; Thomas M. Lietman, MD

Context:  Treatment recommendations assume that repeated mass antibiotic distributions can control, but not eradicate or even locally eliminate, the ocular strains of chlamydia that cause trachoma. Elimination may be an important end point because of concern that infection will return to communities that have lost immunity to chlamydia after antibiotics are discontinued.

Objective:  To determine whether biannual treatment can eliminate ocular chlamydial infection from preschool children and to compare results with the . . . [Full Text of this Article]